Bill
S 2392
Authorizes medical cannabis for treatment of sickle cell anemia.
2024-2025 Regular Session
Introduced by Angela McKnight and 2 co-sponsors
New Jersey bill adds sickle cell anemia to medical cannabis qualifying conditions, allowing patients physician-approved access to cannabis for pain management.
Referred to Senate Budget and Appropriations Committee